Publishing research using ab169755? Please let us know so that we can cite the reference in this datasheet.
ab169755 has been referenced in 8 publications.
- Li C et al. Correlation of LOX-5 and COX-2 expression with inflammatory pathology and clinical features of adenomyosis. Mol Med Rep 19:727-733 (2019). PubMed: 30387822
- Oguh-Olayinka L et al. The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma. Pathol Oncol Res N/A:N/A (2019). PubMed: 30941737
- Khophai S et al. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. Onco Targets Ther 11:7019-7029 (2018). PubMed: 30410359
- Rodríguez-Blanco G et al. Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer. Oncotarget 9:36444-36456 (2018). PubMed: 30559929
- Zuo G et al. Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats. Mol Brain 11:9 (2018). PubMed: 29439730
- Menkhorst EM et al. Invasive trophoblast promote stromal fibroblast decidualization via Profilin 1 and ALOX5. Sci Rep 7:8690 (2017). PubMed: 28821715
- Li C et al. Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism. Sci Rep 6:36949 (2016). WB . PubMed: 27833128
- Che XH et al. Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro. Oncol Rep 35:1680-8 (2016). PubMed: 26707712